Can Thyroid Eye Disease Cause Washed-Out Color Vision?
At a Glance
Washed-out or faded colors—especially red appearing brown—can be an early sign of optic nerve compression from severe thyroid eye disease, even when vision is 20/20. Seek a same-day eye assessment; urgent treatment can help protect sight.
In this answer
5 sections
If colors are starting to look washed out, faded, or dull—especially if vibrant reds look brown or less intense—this is a critical warning sign that requires an urgent, same-day eye assessment. In Thyroid Eye Disease (TED), this change in color perception can be an early indicator of Dysthyroid Optic Neuropathy (DON), a rare but sight-threatening complication where enlarged tissues crowd the optic nerve [1][2]. While other eye issues can also affect color vision, you should seek immediate evaluation from an eye specialist to protect your sight.
What I Should Do Today
- Contact a specialist: Call your neuro-ophthalmologist, ophthalmologist, or specialized thyroid eye center for a same-day urgent appointment [1].
- When to use the Emergency Department: Go to the nearest ED if you cannot be seen today, or if you experience sudden vision loss, rapidly dimming vision, or new blind spots [3].
- Do not drive: Have someone else drive you if your vision is altered in any way.
Why Are Colors Fading?
The optic nerve is the critical cable connecting your eye to your brain. In severe Thyroid Eye Disease, the extraocular muscles and sometimes the fat behind the eye become enlarged [1][4]. Because the eye socket (orbit) is a confined bony space, these enlarged tissues can crowd the back of the socket (the orbital apex) and put pressure on the optic nerve [1].
Loss of color vision—clinically called dyschromatopsia—happens because optic nerve function is impaired by this crowding [1]. Patients often notice “red desaturation,” a phenomenon where red objects lose their vibrancy and appear brown, dull, or gray.
Normal Vision Doesn’t Mean You’re Safe
A crucial danger with DON is that your visual acuity—your ability to clearly read letters on a standard eye chart—can remain completely normal (20/20 or 6/6) even while the optic nerve is compromised [5][3].
Color vision changes often happen before your central vision becomes noticeably blurry [6][7]. Never ignore faded colors just because you can still read clearly. Diminishing color vision requires action regardless of how sharp your vision seems.
What to Expect at the Eye Doctor
Because DON can cause irreversible vision loss if ignored, your clinical team will perform a comprehensive evaluation [1][8]. DON is a rare complication, and prompt assessment is intended to protect your vision. No single test proves or disproves DON; the specialist interprets the whole picture [4]. Your assessment will likely include:
- Formal color vision tests: To objectively measure color perception [1].
- Pupil examination: To check for a Relative Afferent Pupillary Defect (RAPD), which occurs when one optic nerve transmits signals weaker than the other. However, if both eyes are affected equally, the pupils might react normally [1][5].
- Visual field testing: To check for missing areas, blind spots, or general dimming in your side or central vision [1][9].
- Optic disc evaluation: The doctor examines the back of the eye. A swollen optic disc suggests pressure, but the disc can also look completely normal in early DON [1].
- Orbital imaging: A CT or MRI scan helps assess the anatomy, showing if enlarged muscles are causing apical crowding. Imaging supports the clinical diagnosis and helps rule out other causes, though it does not replace the physical eye exam [1][4].
Treatment Options
If DON is diagnosed, prompt specialist-directed treatment is required [1][8]. Note: Never start, stop, or adjust steroid medications on your own.
Medical Therapy: The first-line treatment is typically high-dose intravenous (IV) corticosteroids, such as methylprednisolone, administered under close hospital or specialist supervision [3][10]. This therapy aims to reduce inflammatory swelling and relieve pressure on the nerve. Because these are very high doses, patients are monitored for risks like high blood sugar, mood or blood pressure changes, and rare but serious liver or cardiovascular complications [11].
Surgery: If your vision continues to worsen, or if the steroids do not adequately improve optic nerve function, your specialist may recommend urgent orbital decompression surgery [3][12]. During this procedure, a surgeon removes small pieces of bone from the eye socket to create more space. While often effective at relieving pressure, it is a significant procedure that carries surgical risks, including new or worsened double vision [3][12].
Common questions in this guide
Can thyroid eye disease make colors look faded or brown?
Can I have optic nerve problems if my vision is still 20/20?
What tests check whether thyroid eye disease is affecting my optic nerve?
What is the usual treatment for dysthyroid optic neuropathy?
When should I go to the emergency department for faded color vision?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on thyrotoxic exophthalmos.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my symptom of faded color vision, can you perform a formal color vision test and check for an afferent pupillary defect?
- 2.Do my symptoms and exam suggest apical crowding of the optic nerve, or could another eye condition explain the color change?
- 3.Should we order an urgent CT or MRI of my orbits to help evaluate the space around my optic nerve?
- 4.If treatment is needed, what are the specific risks and monitoring requirements for high-dose intravenous steroids?
- 5.At what point would we consider orbital decompression surgery if medical treatment doesn't adequately relieve the pressure?
References
References (12)
- 1
Dysthyroid Optic Neuropathy.
Potvin ARGG, Pakdel F, Saeed P
Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S65-S80 doi:10.1097/IOP.0000000000002555.
PMID: 38054987 - 2
[Endocrine orbitopathy: the present view of a clinical endocrinologist].
Jiskra J
Vnitrni lekarstvi 2017; (63(10)):690-696.
PMID: 29127744 - 3
Dysthyroid optic neuropathy: emerging treatment strategies.
Pelewicz-Sowa M, Miśkiewicz P
Journal of endocrinological investigation 2023; (46(7)):1305-1316 doi:10.1007/s40618-023-02036-0.
PMID: 36802028 - 4
Diagnostic methods for dysthyroid optic neuropathy: A systematic review and analysis.
Sio SWC, Chan BKT, Aljufairi FMAA, et al.
Survey of ophthalmology 2024; (69(3)):403-410 doi:10.1016/j.survophthal.2023.11.009.
PMID: 38007201 - 5
RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy.
Gupta V, Das S, Mohan S, Chauhan U
Journal of family medicine and primary care 2022; (11(1)):370-375 doi:10.4103/jfmpc.jfmpc_1298_21.
PMID: 35309667 - 6
A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.
Garip Kuebler A, Halfter K, Reznicek L, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2021; (259(11)):3421-3426 doi:10.1007/s00417-021-05227-8.
PMID: 34159407 - 7
Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy.
Garip-Kuebler A, Halfter K, Reznicek L, et al.
The British journal of ophthalmology 2021; (105(7)):1019-1023 doi:10.1136/bjophthalmol-2020-316433.
PMID: 32699051 - 8
Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.
Sakurai K, Inoue T, Niitsuma S, et al.
The Tohoku journal of experimental medicine 2020; (252(4)):321-327 doi:10.1620/tjem.252.321.
PMID: 33268601 - 9
Utility of isolated-check visual evoked potential technique in dysthyroid optic neuropathy.
Luo B, Liu R, Wang S, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2023; (261(7)):2031-2040 doi:10.1007/s00417-023-05975-9.
PMID: 36642765 - 10
Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.
Tagami M, Honda S, Azumi A
Clinical ophthalmology (Auckland, N.Z.) 2022; (16()):841-850 doi:10.2147/OPTH.S284609.
PMID: 35330749 - 11
Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.
Riedl M, Kolbe E, Kampmann E, et al.
Journal of endocrinological investigation 2015; (38(2)):177-82 doi:10.1007/s40618-014-0227-x.
PMID: 25576458 - 12
Updates on Treatment in Thyroid Eye Disease for the Neurologist.
Alryalat SA, Alasheh A, Salim QA, Yaaqba N
Neurologic clinics 2026; (44(2)):321-335 doi:10.1016/j.ncl.2025.12.002.
PMID: 41922040
This page is for informational purposes only and does not constitute medical advice. New or worsening color or vision changes with thyroid eye disease require prompt assessment by an eye specialist.